Valsartan-Amlodipine
- Generic Name
- Valsartan-Amlodipine
Overview
No overview information available.
Background
No background information available.
Indication
治疗原发性高血压。用于单药治疗不能充分控制血压的患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/05 | Phase 4 | Completed |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
Singapore Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. | Online |
|---|
No Singapore products found
No Singapore products found for this drug
China Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
Valsartan and Amlodipine Tablets（Ⅱ） | 国药准字H20254234 | 石家庄市华新药业有限责任公司 | 片剂 | N/A | 每片含缬沙坦160mg，氨氯地平5mg | Chemical Drug | Approved | 2025/05/20 | Domestic |
缬沙坦氨氯地平片(Ⅱ) | H20140628 | Novartis Pharma Schweiz AG | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Approved | N/A | Domestic | |
缬沙坦氨氯地平片(Ⅱ) | H20150083 | Novartis Pharma Schweiz AG | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Approved | N/A | Domestic | |
Valsartan and Amlodipine Tablets (II) | 国药准字J20180004 | novartis farmaceutica sa | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Chemical Drug | Approved | 2018/01/08 | Import |
Valsartan and Amlodipine Tablets (II) | H20171191 | novartis farmaceutica sa | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Chemical Drug | Expired | 2017/09/14 | Import |
缬沙坦氨氯地平片(Ⅱ) | 国药准字H20140628 | Novartis Pharma Schweiz AG | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Chemical Drug | Approved | N/A | Domestic |
Valsartan and Amlodipine Tablets (II) | J20180004 | novartis farmaceutica sa | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Chemical Drug | Approved | 2018/01/08 | Import |
Valsartan and Amlodipine Tablets (II) | H20171190 | novartis farmaceutica sa | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Chemical Drug | Expired | 2017/09/14 | Import |
缬沙坦氨氯地平片(Ⅱ) | 国药准字J20150086 | Novartis Pharma Schweiz AG | 片剂 | N/A | 每片含缬沙坦160mg、氨氯地平5mg | Imported Drug | Approved | N/A | Domestic |
Valsartan and Amlodipine Tablets（Ⅱ） | 国药准字H20223139 | 广州玻思韬控释药业有限公司 | 片剂 | N/A | 每片含缬沙坦160mg，氨氯地平5mg | Chemical Drug | Approved | 2022/03/16 | Domestic |
Australia Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No Australia products found
No Australia products found for this drug
© Copyright 2025. All Rights Reserved by MedPath